Clinical Trials Logo

Filter by:
NCT ID: NCT02157402 Completed - Obesity Clinical Trials

EYTO (European Youth Tackling Obesity): A Randomized Controlled Trial in Catalonia (Spain)

EYTO-SPAIN
Start date: May 2014
Phase: N/A
Study type: Interventional

Our hypothesis is that healthy lifestyles improvement by an intervention designed according 8 social marketing Benchmark criteria, can reduce overweight or obesity implemented by adolescents on their colleges. The general aim of EYTO program is to improve health and well-being among adolescents who live in low socioeconomically communities, through an intervention study designed by selected adolescents with the inclusion of social marketing Benchmark criteria.

NCT ID: NCT02156804 Completed - Melanoma Clinical Trials

A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody (CheckMate 172)

Start date: October 7, 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the rate and frequency of high-grade (CTCAE v4.0 Grade 3 or higher), treatment-related, select adverse events in subjects with histologically confirmed stage III (unresectable) or stage IV melanoma and progression post prior treatment containing an anti-Cytotoxic T Lymphocyte Antigen (CTLA-4) monoclonal antibody, treated with Nivolumab (BMS-936558) at a dose of 3 mg/kg every two weeks.

NCT ID: NCT02155647 Completed - Clinical trials for Carcinoma, Merkel Cell

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Start date: July 3, 2014
Phase: Phase 2
Study type: Interventional

This is a multicenter, international, single-arm, open-label, Phase 2 trial to evaluate the efficacy and safety of avelumab in participants with metastatic Merkel cell carcinoma (MCC).

NCT ID: NCT02155179 Completed - Oligospermia Clinical Trials

Sperm Pathology Samples and Morphokinetics

Start date: August 2014
Phase:
Study type: Observational

The embryo kinetics may be a new prognostic factor for choosing the embryos with the highest implantation potential. In order to identify the factors that may affect the rate of embryo cleavage, there are many studies about morphokinetics and culture medium, oxygen tension, oocyte quality or type of medication used for ovarian stimulation. However there are no published data with respect to the influence of semen quality in the embryo kinetic. In this study The investigators propose that the sperm quality may has influence in the embryo division.

NCT ID: NCT02154776 Completed - Clinical trials for Advanced or Metastatic Breast Cancer

Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.

LeeBLet
Start date: June 27, 2014
Phase: Phase 1
Study type: Interventional

This is a multi-center, open-label, non-randomized, phase I study

NCT ID: NCT02153879 Completed - Clinical trials for Type 2 Diabetes Mellitus

Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment

LOWHDL
Start date: February 2009
Phase: Phase 4
Study type: Interventional

The structural and functional alterations of high density lipoproteins (HDL) levels in type 2 diabetes (T2D) patients linked to hypertriglyceridemia, hyperglycemia, insulin resistance, inflammation and oxidation, play a major role in the increased macrovascular risk in these patients. An impaired function of the adipose tissue (AT) in T2D contributes to low HDL concentrations. Objectives: 1) Quantitative and qualitative characterisation of HDL subclasses by ultracentrifugation, proteomic and metabolomic techniques. 2) To study the relationship between the HDL subclasses, preβ1 HDL and remnant HDL, and clinical determinants of arteriosclerosis. 3) Functional in vitro studies of the HDL subclasses determined in Objective 1. 4) To study the role of AT determining the low HDL levels. 5) To study the impact of HDL increasing drugs on HDL qualitative changes.

NCT ID: NCT02153047 Completed - Smoking Cessation Clinical Trials

Multicentric Randomized Clinical Trial to Evaluate the Long-term Effectiveness of a Motivational Intervention Against Smoking, Based on the Information Obtained From Spirometry in Primary Care.

RESET-ESPITAP2
Start date: November 2011
Phase: N/A
Study type: Interventional

There is controversy about the effectiveness of interventions based on spirometry for smoking cessation. The investigators want to evaluate the effectiveness of motivational intervention performed by a doctor to obtain abstinence compared with normal practice in primary care. This study, is the second half of what was began with ESPITAP study

NCT ID: NCT02152761 Completed - Clinical trials for Muscle Wasting (Atrophy) After Hip Fracture Surgery

Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery

Start date: September 16, 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study was to assess if bimagrumab is safe and effective in patients with muscle wasting (atrophy) after hip fracture surgery.

NCT ID: NCT02152371 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes

AWARD-9
Start date: May 2014
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to evaluate the use of the study drug known as dulaglutide in participants with type II diabetes who are taking once-daily insulin glargine. The study will last about 31 weeks for each participant.

NCT ID: NCT02151682 Completed - Pain Clinical Trials

A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain

Start date: April 29, 2015
Phase: Phase 2/Phase 3
Study type: Interventional

Tapentadol has already been studied in adults. This study is needed to find out if tapentadol works and is safe to use in children and adolescents with long-term pain.